Transforming growth factor-beta 1 (TGF) and T lymphocytes regulate the growth of day 14 CFU-GM from peripheral blood (PB)

Cytokine ◽  
1989 ◽  
Vol 1 (1) ◽  
pp. 104
2014 ◽  
Vol 14 (3) ◽  
pp. 156 ◽  
Author(s):  
Rasoul Baharlou ◽  
Abbas Ahmadi Vasmehjani ◽  
Ali Dehghani ◽  
Mohamed Amin Ghobadifar ◽  
Mahshid Khoubyari

1993 ◽  
Vol 13 (2) ◽  
pp. 1155-1162 ◽  
Author(s):  
T Brabletz ◽  
I Pfeuffer ◽  
E Schorr ◽  
F Siebelt ◽  
T Wirth ◽  
...  

Transforming growth factor beta (TGF-beta) has a growth-inhibitory effect on numerous different cell types of the immune system, including T lymphocytes. We show in this study that the inhibitory action of TGF-beta on T lymphocytes is accompanied by a block of interleukin 2 (IL-2) gene expression which is mediated, at least in part, by inhibition of IL-2 promoter/enhancer activity. The functional analysis of cis-regulatory (proto-enhancer) elements of the IL-2 enhancer/promoter region showed that the most TGF-beta-responsive element maps to its so-called upstream promoter site. The proto-enhancer activity of the upstream promoter site element is also inhibited by cyclosporin A. The upstream promoter site DNA harbors two noncanonical, closely linked binding sequences for octamer and AP-1-like factors. Both sites are involved in the establishment of IL-2 enhancer activity. Since the activity of genuine octamer sites but not that of AP-1-binding sites is also impaired by TGF-beta and cyclosporin A in El4 T lymphoma cells, we conclude that both immunosuppressives interfere with the activity but not the DNA binding of octamer factors in T lymphocytes.


Sign in / Sign up

Export Citation Format

Share Document